Argon laser with and without anti-vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy. [electronic resource]
Producer: 20130314Description: 295-304.e1 p. digitalISSN:- 1879-1891
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Bevacizumab
- Choroid -- blood supply
- Choroid Diseases -- diagnosis
- Coloring Agents
- Combined Modality Therapy
- Female
- Fluorescein Angiography
- Follow-Up Studies
- Fovea Centralis
- Humans
- Indocyanine Green
- Intravitreal Injections
- Laser Therapy
- Lasers, Excimer -- therapeutic use
- Male
- Middle Aged
- Polyps -- diagnosis
- Prospective Studies
- Ranibizumab
- Tomography, Optical Coherence
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.